Listening, learning, collaborating
We collaborate with the SAB toward solutions to solve clinical research challenges, from protocol design and patient-focused drug development to technology use and the inclusion of difficult to reach populations.
We bring fresh thinking and new perspectives from large and small sites and drug developers, as well as members from different global regions and backgrounds.
Together, we pursue opportunities for streamlining clinical trial operations, optimizing study design and implementing innovative technologies. Pulling from our collective expertise and insights, the board helps us develop strategies that provide tangible results, enhancing the clinical trial experience for sponsors, sites and patients. It all adds up to a diverse mix of input that helps us develop and share best practices and novel solutions to make trials better.